Biomedical subjects

G C Mews

Publications and source records attributed to G C Mews.

7 recordsLinked to original sources

PubMed1992

Use of twenty-four hour infusions of intracoronary tissue plasminogen activator to increase the application of coronary angioplasty.

Coronary arteries occluded by long lengths of thrombus are usually considered unattractive for angioplasty. Nine patients (8 male, mean age 50.1 years) undergoing angiography for unstable angina were found to have single vessel disease considered unsuitable for angioplasty as the vessel was occluded by a long length of thrombus. These patients were treated with 24 hr intracoronary infusions of 100 mg tPA in an attempt to make angioplasty feasible. Marked thrombolysis occurred in 7 patients who received uncomplicated infusions. One case was unsuccessful due to catheter displacement, while another had the infusion ceased due to an intracerebral bleed from a previously silent A-V malformation. This was the only major complication. Angioplasty was attempted in 6 of 7 cases where lysis had been achieved, with success in all lesions attempted. This reports shows that intracoronary tPA infused over prolonged periods produces excellent thrombolysis, making angioplasty feasible in some patients who were previously unsuitable.

Angina, Unstable↗

PubMed1991

Effects of low-dose aspirin on restenosis after coronary angioplasty.

After angioplasty of a previously untreated native coronary artery and after 2 weeks of aspirin therapy, 216 subjects (aged less than 70 years without acute infarction) were randomized to treatment with soluble aspirin, 100 mg/day, or placebo to study the effect on restenosis. Follow-up, defined as angiography at 6 months, earlier angiographic restenosis or coronary bypass surgery was completed by 108 aspirin- and 104 placebo-treated patients. Restenosis (stenosis greater than or equal to 50% plus loss of greater than or equal to 50% of gain, or surgery) occurred in 38 (35%) aspirin- and 45 (43%) placebo-treated subjects (p = not significant). No patient died. Restenosis occurred in 42 of 168 (25%) aspirin- and 51 of 135 (38%) placebo-treated lesions (p less than 0.025). Aspirin-treated lesions (n = 163) had lost 16 +/- 22% (mean +/- standard deviation) of lumen and placebo-treated lesions 22 +/- 25% of lumen (n = 134) at angiography (p less than 0.01). There were more left anterior descending lesions in the placebo group and these had a higher recurrence rate than other lesions. The beneficial effect of aspirin was not dependent on this, although significance was reduced in subgroup analysis. Loss of lumen in left anterior descending lesions was 20 +/- 24% (n = 57) in the aspirin-treated and 27 +/- 25% (n = 70) in the placebo-treated lesions (p less than 0.1). It is concluded that there is a small beneficial effect of low-dose aspirin on restenosis after coronary angioplasty.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

PubMed1990

Update on percutaneous transluminal coronary angioplasty and CABG.

Over the past decade percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) have undergone substantial changes. The growth of PTCA has been phenomenal and it now accounts for about 50 per cent of revascularisation procedures at Royal Perth Hospital. Coronary surgery has undergone less growth, but it is now being successfully used in a much more elderly and high risk group of patients without an increase in mortality.

Angioplasty, Balloon, Coronary↗

PubMed1989

Long term efficacy of transvenous catheter ablation of the atrioventricular junction for refractory supraventricular tachycardia.

Twenty-four patients who underwent transvenous catheter ablation of the atrioventricular (A-V) junction between November 1982 and February 1987 were followed from 18-72 months (mean 47.9) to assess the long term efficacy and safety of the procedure. All had severely symptomatic supraventricular tachyarrhythmias refractory to standard treatment. Atrioventricular conduction was abolished in 23 patients, 22 having permanent pacemakers implanted. Conduction has recovered, though it is modified, in one patient who is asymptomatic on digoxin. Four patients have died; one suddenly 20 months following the procedure, one of progressive heart and liver failure due to hemochromatosis, and two of a stroke. Four patients have had complications related to permanent pacing; one patient has required generator replacement and one patient ventricular lead replacement, one patient had asystole and one patient had a pacemaker-related tachycardia. Two patients remain symptomatic but improved by the procedure. Seventeen patients are free of their original symptoms, 11 having no intervening morbid events. These results demonstrate that patients with severely symptomatic supraventricular tachyarrhythmias may gain long term symptomatic relief from the procedure, but permanent pacing is a cause of significant morbidity and there is a small incidence of late sudden cardiac death.

Adult↗

PubMed1986

Echocardiographic characterization of dilatation cardiomyopathy in the English cocker spaniel.

The echocardiographic characterization of a dilatation cardiomyopathy in small-breed dogs is reported. Twelve clinically healthy adult English Cocker Spaniel dogs (between 2 and 9 years old and weighing 11.5 to 15.4 kg [mean 12.9 +/- 1.00 kg]) from a kennel population with a history of cardiomyopathy were assessed, using M-mode echocardiography. The dogs were selected on ECG and/or radiographic evidence of ventricular enlargement. Nine dogs had R-wave amplitude in lead 11 of greater than 3.0 mV. Two dogs had an unusual right-axis deviation, the result of deep Q waves in the limb leads and deep S waves in chest leads CV6LL and CV6LU, indicating that there was right ventricular enlargement. All dogs had increased end-systolic dimensions (mean 3.0 +/- 0.6 cm). End-diastolic dimensions were increased in 9 dogs (mean 4.0 +/- 0.5 cm), and there was a decrease of left ventricular (LV) function as measured by fractional shortening in 8 dogs. Mean fractional shortening for the 12 dogs was 25.4 +/- 5.7%. There was significant correlation between LV dimensions and age at echocardiographic assessment, indicating that LV dilatation was progressive. Three of the oldest dogs had severe dilatation of the LV, and in 2 of these, LV function was severely decreased. Left ventricular function in the 3rd dog, however, was within the acceptable range. Fractional shortening and thickness of the LV caudal wall and interventricular septum were significantly correlated (P less than 0.01 for interventricular system and P less than 0.05 for LV caudal wall).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1986

Echocardiographic assessment of left ventricular dimensions in clinically normal English cocker spaniels.

Seventeen clinically normal adult English Cocker Spaniels from a kennel population with a history of cardiomyopathy were assessed, using M-mode echocardiography, to establish reference values for left ventricular (LV) dimensions for this breed of dog. Echocardiographic measurements were compared with postmortem measurements in 10 of 17 dogs. The LV weight calculated from the echocardiographic measurements correlated significantly with LV weight at postmortem (P less than 0.05). Echocardiographic measurements of end diastolic and end systolic diameters for the 17 dogs correlated significantly with body surface area (P less than 0.01). Measurements of the interventricular septum were in close agreement with values in clinically normal dogs and were significantly correlated with postmortem measurements (r = 0.94, P less than 0.01). However, 76% of the measurements for LV caudal wall thickness in this group of dogs were above the normal range. Calculation of fractional shortening values identified a group of 5 dogs with reduced fractional shortening (mean +/- SD, 20.97 +/- 3.66%), which indicates that a depression in contractility may be present in some apparently healthy dogs of this kennel population. The remaining 12 dogs had fractional shortening values of mean +/- SD, 34.26 +/- 4.54%.

Animals↗

PubMed1985

Initial experience with physiological pacing.

Fifty patients, aged 23 to 88 years, with permanent rate-responsive dual chamber pacemakers were studied prospectively for 14.1 +/- 11.4 (S.D.) months after implantation to assess the benefits and complications associated with this technique. In 12 patients the device replaced a ventricular demand pacemaker. Minor complications associated with implantation occurred in one case. Atrial leads required repositioning because of increase in threshold and/or problems of sensing in five cases and ventricular leads in five. There were two patients with symptomatic pacemaker-related arrhythmias necessitating reprogramming; one patient with pacemaker-mediated tachycardia and one with pacemaker autoinhibition. Seven patients have died; one suddenly and possibly related to a pacemaker-triggered arrhythmia. Of 43 living patients, five are now programmed to the ventricular demand mode; two with atrial fibrillation, one with failed atrial lead repositioning, one with persistent sinus tachycardia, and one because of angina pectoris. Thirty-six of the 43 living patients are asymptomatic and a further six are symptomatically improved. All 12 patients changed from ventricular demand pacing have less symptoms. Rate-responsive dual chamber pacing is safe and appears to improve symptoms in most cases. Complications are infrequent and usually easily overcome. This mode of pacing should be considered in all patients with normal sinoatrial function in whom a permanent pacemaker is indicated.

Adult↗